People hear "five to seven weeks" and assume we skipped something. Research, maybe, or a round of strategy. We didn't skip anything. We removed the parts of a planning cycle where nothing was actually happening: the waiting between meetings, the queue for review, the week a deck sits in someone's inbox before anyone opens it.
This is Part 6 of our Brand Planning series. Part 1 looked at how long traditional agency engagements run. This one breaks down what five to seven weeks to an approved 2027 plan actually looks like, so it's not just a number.
Leg One, Two to Three Weeks: Sections 1 to 4
Planning starts with what you already have: where the brand stands, this year's milestones hit and missed, research you already own, your payer position, and your immovable dates. You bring your budget ceiling, not a locked allocation, because the allocation is something the plan produces. You don't bring a finished brief either. The Navigator who builds the strategy writes it, because intent degrades every time it gets handed off.
From there, Leg One builds the foundation: the executive summary (which starts as the intake brief and gets finished last), the market landscape and disease overview, insights and situation analysis covering the patient journey, HCP barriers, and payer position, and brand strategy and positioning.
Two things make this leg fast. First, your review body is at the table from Section 1. MLR on the commercial side, IRB or EC on the clinical side, legal or regulatory on the communications side. Constraints get found while they're still cheap to design around. Second, Clinical, Commercial, and Communications advance in parallel, not one after another.
Checkpoint 1: The Alignment Gate
Positioning arrives as territories, each with its full reasoning, so you can judge whether we have it right. This is where direction gets confirmed or corrected, and correcting it here costs a conversation instead of a rebuild. You also aren't paying for polished platform language on positions you'll never use.
Leg Two, Three to Four Weeks: Sections 5 to 8
Leg Two builds the plan you'll execute, on the direction you approved at Checkpoint 1. It starts with the tactical execution plan and scoping: what gets built, what it takes, and no scope that quietly grows while nobody is looking. That scoping happens here because you can't scope execution before the plan exists. From there: trends worth investing in (each one vetted before it reaches the page), financials and KPIs, and the timeline and risk register. Every budget line traces back to a strategic choice made in Section 4, so when leadership asks why this number and not that one, the answer is in the plan.
Checkpoint 2: An Approved Plan
The full plan, review-cleared, positioning finished. Approve it and it becomes a project that week. There's no translation stage, because it was built to be executed, not presented.
Why the Traditional Version Takes Longer
It isn't that the work takes longer. Each stage waits for the one before it to close, lanes run in sequence, and review sees the plan for the first time at the end. When review finds a problem late, the plan loops back. Most review bottlenecks aren't the reviewers being slow. They're the reviewers being asked last.
The Bigger Point
A shorter planning cycle isn't a thinner plan. It's the same eight sections with the idle time removed, and with protected thinking time put on the schedule first instead of squeezed out of it later. If your 2027 plan needs to be real and done in weeks, that's what makes it possible.
To walk through what this looks like for your brand, reach out.
Other articles from the brand planning series:
It's Not Too Late to Build a 2027 Plan. It's Just Too Late to Do It the Old Way.
Labor Day Checkpoint: Five Questions Before Year-End
Expensive Theater: The Marketing Plan Compliance Kills in One Meeting
The Spreadsheet Can Wait. The Thinking Can't.
2027 Brand Planning Starts Now. Most Companies Are About to Get the Timeline Wrong.
